Results 101 to 110 of about 94,588 (272)
Advanced Science, Volume 13, Issue 16, 18 March 2026.An integrated approach that combines a DNA nanoflower VEGF degrader with photodynamic therapy is developed for the treatment of wet age‐related macular degeneration, which reduces the risk of VEGF reactivation‐induced CNV recurrence and minimizes the systemic side effects associated with photodynamic therapy.
Mengxuan Li +11 more
wiley +1 more source
Acute sterile endophthalmitis following intravitreal bevacizumab: case series
, 2014 Axel Orozco-Hernández,1 Ximena Ortega-Larrocea,1 Gustavo Sánchez-Bermúdez,1 Gerardo García-Aguirre,1 Virgilio Morales Cantón,1 Raul Velez-Montoya2 1Retina Department, Asociación para Evitar la Ceguera en M ...
Ortega-Larrocea X +5 more
core
, 2011 Hatem M Marey, Amin F EllakwaOphthalmology Department, Minoufiya University, EgyptPurpose: To compare the efficacy of intravitreal injection of bevacizumab alone or combined with intravitreal triamcinolone as the primary treatment for cases with diabetic
Amin Faisal Ellakwa +3 more
core +1 more source
Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation
, 2014 Victor M Villegas,1 Aaron S Gold,1 Audina M Berrocal,2 Timothy G Murray11Ocular Oncology and Retina, Miami, FL, USA; 2Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USAPurpose: To ...
Berrocal AM +3 more
core
Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
, 2014 Ricardo Lemos-Reis,1 Nuno Moreira-Gonçalves,1 António B Melo,1 Ângela M Carneiro,1,2 Fernando M Falcão-Reis1,2 1Department of Ophthalmology of Hospital de São João, Porto, Portugal; 2Department of Sense Organs ...
Lemos-Reis R +4 more
core
Bevacizumab Is Not Toxic to Retinal Ganglion Cells after Repeated Intravitreal Injection
, 2011 Purpose: The cytotoxicity of single and repeated administration of bevacizumab to retinal ganglion cells was studied in vivo and in vitro. Methods: Rats received single or repeated injections of 125 mu g of bevacizumab into the vitreous cavity of the ...
CHENG, CHENG-KUO;PENG, PAI-HUEI;TIEN, LU-TAI;CHEN, CHAU-FONG;LEE, YIH-JING +1 more
core +1 more source
Journal of Rawalpindi Medical College, 2016 Background: To study the rate of different complications of intravitreal Bevacizumab while treating patients of different posterior segment diseases. Methods: A prospective study of 60 patients having different retinal diseases like diabetic retinopathy, wet age related macular degeneration (AMD), retinal vein occlusion (RVO),was carried out.
openaire +1 more source
Intravitreal bevacizumab for treatment of central serous chorioretinopathy
Journal of Ophthalmic and Vision Research, 2016 To compare the outcomes of treatment with intravitreal bevacizumab (IVB) versus observation in central serous chorioretinopathy (CSCR).In a retrospective comparative study, records of 45 patients with CSCR were reviewed. Twenty-two patients received IVB (1.25 mg/0.05 ml) while 23 subjects were observed.
Cihan Ünlü +6 more
openaire +3 more sources
Macular hole after intravitreal bevacizumab injection for choroidal neovascularisation [PDF]
, 2013 PurposeThe aim of this study was to report a patient who developed a full-thickness macular hole following intravitreal bevacizumab injection. MethodsA 78-year-old patient diagnosed with choroidal neovascularisation (CNV) was treated with intravitreal ...
Tufan, Hasan Ali +5 more
core +1 more source
Aggressive retinal astrocytoma associated with tuberous sclerosis
Clinical Ophthalmology, 2012 Machiko Tomida,1 Yoshinori Mitamura,1 Takashi Katome,1 Hiroshi Eguchi,1 Takeshi Naito,1 Takayuki Harada21Department of Ophthalmology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, 2Visual Research Project, Tokyo
Tomida M +5 more
doaj